Latest Period
n/a
Security Snapshot
AEON Biopharma, Inc. - Class A Common Stock (AEON) Institutional Ownership
CUSIP: 00791X100
13F Institutional Holders and Ownership History from Q3 2023 to Q1 2025
Institutions Reporting
Shares (Excl. Options)
Price
$0.07
- Type / Class
- Equity / Class A Common Stock
- Symbol
- AEON on NYSE
- Shares outstanding
- 39,736,842
- Price per share
- $0.07
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors
Quick Takeaways
- AEON - AEON Biopharma, Inc. - Class A Common Stock is tracked under CUSIP 00791X100.
- Latest finished 13F holder period is not available.
- 4 significant owners is listed from Schedule 13D/13G reporting.
What Changed
- Holder count moved from 36 to 0 between Q4 2024 and Q1 2025.
- Reported value moved from $4,795,828 to $0.
Why This Matters
- You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
- 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.
Official SEC Source
Backed by Schedule 13D/13G
Ownership context comes from SEC Form 13F and, when available, Schedule 13D/13G filings.
See Original FilingInvestment Quick Answers
What is CUSIP 00791X100?
CUSIP 00791X100 identifies AEON - AEON Biopharma, Inc. - Class A Common Stock in SEC 13F datasets.
Where can I see the latest institutional holders?
Use the ownership history tables below to review the newest available institutional filing periods.
Continue Investment Research
- Latest 13F filings for new institutional portfolio disclosures.
- Latest Schedule 13D/13G reports for activist and beneficial ownership updates.
- Latest 10-Q/10-K reports to cross-check issuer fundamentals.
- Recent insider transactions for management buying/selling context.
- SEC investors directory and top value investors for manager-level discovery.
- All institutional ownership pages to compare adjacent CUSIP pages.
Recent Quarterly Holder Reports
Open recent reporting periods for CUSIP 00791X100:
Significant Owners of AEON Biopharma, Inc. - Class A Common Stock (AEON) based on Schedule 13D/G filings
| Filer | Ownership | Change % | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|
| BIGGER CAPITAL FUND L P | 6.1% | $343,000 | 4,900,000 | Bigger Michael | 06 Jan 2025 | |||
| Blue Owl Capital Holdings LP | 3.8% | $213,455 | 3,049,361 | Blue Owl Capital Holdings LP | 31 Dec 2024 | |||
| PALMISANO ROBERT J | 5.7% | 0% | $158,550 | 2,265,000 | 0% | Robert J Palmisano | 25 Jul 2024 | |
| L1 Capital Global Opportunities Master Fund, Ltd. | 4.1% | -59% | $32,552 | -$594,648 | 465,029 | -95% | L1 Capital Global Opportunities Master Fund, Ltd. | 31 Mar 2025 |
Institutional Holders of AEON Biopharma, Inc. - Class A Common Stock (AEON) across Reporting Periods
| Period | Reported Shares, Excl. Options | Value, Excl. Options | Value Change | Price (Median) | Investors |
|---|---|---|---|---|---|
| 2025 Q1 | 0 | $0 | -$4,795,828 | $0.07 | 0 |
| 2024 Q4 | 8,880,478 | $4,795,828 | -$377,954 | $0.54 | 36 |
| 2024 Q3 | 9,572,064 | $10,050,752 | +$4,021,961 | $1.05 | 30 |
| 2024 Q2 | 9,423,837 | $8,730,840 | -$432,476 | $1.05 | 25 |
| 2024 Q1 | 9,471,590 | $103,476,438 | +$9,336,116 | $11.60 | 26 |
| 2023 Q4 | 8,666,712 | $56,800,421 | +$26,503,906 | $7.20 | 20 |
| 2023 Q3 | 4,751,382 | $25,855,744 | +$24,411,072 | $5.60 | 15 |